4.7 Article

Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer

Journal

MOLECULAR NUTRITION & FOOD RESEARCH
Volume 61, Issue 12, Pages -

Publisher

WILEY
DOI: 10.1002/mnfr.201700445

Keywords

BODIPY-cholesterol; fluidity; HDL; HDL cholesterol efflux capacity; virgin olive oil

Funding

  1. Spanish Ministry of Economy (MINECO) [AGL2009-13517-457 C03-01, AGL2009-13517-457 C03-02, AGL2009-13517-457 C03-3, AGL2012-40144-C01-03, AGL2012-40144-C02-03, AGL2012-40144-C03-03]
  2. FPI-fellowship [BES-2010-040766]
  3. IISPV [CD14/00275]
  4. Eurecat-CTNS
  5. ISCIII [JR14/00008]
  6. intramural National Heart, Lung and Blood Institute of the National Institutes of Health, in Bethesda, MD

Ask authors/readers for more resources

Scope Cholesterol efflux capacity of HDL (CEC) is inversely associated with cardiovascular risk. HDL composition, fluidity, oxidation, and size are related with CEC. We aimed to assess which HDL parameters were CEC determinants after virgin olive oil (VOO) ingestion. Methods and results Post-hoc analyses from the VOHF study, a crossover intervention with three types of VOO. We assessed the relationship of 3-week changes in HDL-related variables after intervention periods with independence of the type of VOO. After univariate analyses, mixed linear models were fitted with variables related with CEC and fluidity. Fluidity and Apolipoprotein (Apo)A-I content in HDL was directly associated, and HDL oxidative status inversely, with CEC. A reduction in free cholesterol, an increase in triglycerides in HDL, and a decrease in small HDL particle number or an increase in HDL mean size, were associated to HDL fluidity. Conclusions HDL fluidity, ApoA-I concentration, and oxidative status are major determinants for CEC after VOO. The impact on CEC of changes in free cholesterol and triglycerides in HDL, and those of small HDL or HDL mean size, could be mechanistically linked through HDL fluidity. Our work points out novel therapeutic targets to improve HDL functionality in humans through nutritional or pharmacological interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available